Science China Life Sciences, Год журнала: 2024, Номер unknown
Опубликована: Ноя. 28, 2024
Язык: Английский
Science China Life Sciences, Год журнала: 2024, Номер unknown
Опубликована: Ноя. 28, 2024
Язык: Английский
Probiotics and Antimicrobial Proteins, Год журнала: 2025, Номер unknown
Опубликована: Янв. 30, 2025
Язык: Английский
Процитировано
2Probiotics and Antimicrobial Proteins, Год журнала: 2025, Номер unknown
Опубликована: Фев. 18, 2025
Язык: Английский
Процитировано
1Archives of Microbiology, Год журнала: 2025, Номер 207(3)
Опубликована: Фев. 23, 2025
Язык: Английский
Процитировано
1International Journal of Biological Macromolecules, Год журнала: 2024, Номер 278, С. 134860 - 134860
Опубликована: Авг. 18, 2024
Язык: Английский
Процитировано
4Journal of Translational Medicine, Год журнала: 2025, Номер 23(1)
Опубликована: Апрель 15, 2025
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects reproductive-aged women worldwide, causing hormonal imbalances and ovarian dysfunction. PCOS metabolic health increases the risk of obesity, insulin resistance, cardiovascular disease, in addition to infertility. This review delves deeper into connections gut microbiota with pathophysiology, particularly its impact on hormone metabolism, inflammation, resistance by way short-chain fatty acids, lipopolysaccharides, gut-brain axis. Studies also show changes processes immune responses are seen subjects, such as Bacteroidetes Firmicutes groups. Some bacteria, like Escherichia Shigella, have been associated dysbiosis patients PCOS, leading systemic inflammation changed levels, which further worsen clinical symptoms. Therapeutic interventions targeting comprise probiotics, prebiotics, fecal transplantation; these potential alleviate symptoms PCOS. Other precision microbiome-based therapies include postbiotics, CRISPR-Cas9 genome editing, relatively new avenues toward treatment. complex interlink pathophysiology will open for possible treatments problems characterize disorders. The here focuses requirement studies be able elucidate specific pathways relating dysregulation and, thus, improve better outcomes affected individuals.
Язык: Английский
Процитировано
0International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(9), С. 4112 - 4112
Опубликована: Апрель 26, 2025
The gut microbiome plays a vital role in human health, functioning as metabolic organ that influences nutrient absorption and overall well-being. With growing evidence dietary interventions can modulate the improve this review examines whether healthcare systems should prioritize personalized microbiome-targeted therapies, such probiotics, prebiotics, microbiota transplants, over traditional pharmaceutical treatments for chronic diseases like obesity, diabetes, cardiovascular risk, inflammatory conditions. A systematic using Web of Science Scopus databases was conducted, followed by scientometric analysis. Key pathways, fiber fermentation short-chain fatty acid production, were explored, focusing on their impact lipid glucose metabolism. interactions between microbial metabolites immune system also investigated. Dietary interventions, including increased probiotic intake, show potential addressing dysbiosis linked to conditions, type 2 autoimmune diseases. emphasizes need incorporate modulation strategies into clinical practice research, calling multidisciplinary approach integrates nutrition, microbiology, biochemistry better understand microbiome's complex health.
Язык: Английский
Процитировано
0Aquaculture, Год журнала: 2024, Номер 588, С. 740924 - 740924
Опубликована: Апрель 12, 2024
Язык: Английский
Процитировано
1Food Chemistry, Год журнала: 2024, Номер 467, С. 142281 - 142281
Опубликована: Ноя. 29, 2024
Язык: Английский
Процитировано
1Science China Life Sciences, Год журнала: 2024, Номер unknown
Опубликована: Ноя. 28, 2024
Язык: Английский
Процитировано
1